Granite Point Capital Management’s Eucrates Biomedical Acquisition Corp. Warrant EUCRW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-133,332
| Closed | -$7.08K | – | 99 |
|
|
2022
Q4 | $7.08K | Hold |
133,332
| – | – | ﹤0.01% | 75 |
|
|
2022
Q3 | $5K | Hold |
133,332
| – | – | ﹤0.01% | 92 |
|
|
2022
Q2 | $9K | Hold |
133,332
| – | – | ﹤0.01% | 97 |
|
|
2022
Q1 | $25K | Hold |
133,332
| – | – | 0.01% | 107 |
|
|
2021
Q4 | $77K | Hold |
133,332
| – | – | 0.01% | 104 |
|
|
2021
Q3 | $107K | Hold |
133,332
| – | – | 0.01% | 109 |
|
|
2021
Q2 | $138K | Hold |
133,332
| – | – | 0.01% | 128 |
|
|
2021
Q1 | $167K | Hold |
133,332
| – | – | 0.01% | 135 |
|
|
2020
Q4 | $188K | Buy |
+133,332
| New | +$188K | 0.01% | 114 |
|